Pharma investor’s award against Ecuador upheld

A Dutch court has upheld a US pharmaceuticals company’s €44 million investment treaty award against Ecuador, dismissing arguments that the arbitrators took on the role of a final appeal court when they held the state liable for a denial of justice.


Get unlimited access to all Global Arbitration Review content